Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cell Impact Q3 2026: New opportunities despite continuing challenges

CIRegulatory press release06.11.2026 klo 09.03
Download the release

During the quarter, Cell Impact completed a rights issue that was 75 percent subscribed and generated proceeds of approximately SEK 40.2 million for the company before issue costs and repayment of bridge financing, including accrued interest.

Cell Impact signed an order with a leading US manufacturer of fuel cells and electrolyzers during the quarter. Deliveries were originally scheduled to take place on an ongoing basis over a two-year period. However, after the end of the quarter, the customer requested earlier deliveries, and final delivery is now scheduled for April 2027.

One significant development after the end of the quarter was the signing of an agreement with Toyota Tsusho Corporation, a global industrial and trading company based in Japan. At the request of a number of undisclosed customers, Cell Impact will perform forming tests on nanocrystalline titanium, a material that is already used by these customers in various mass production applications.

"Our focus is clear: we will continue to develop our existing customer relationships with the aim of moving into regular production, while expanding the use of our technology and expertise into new markets. The progress we have made to date now needs to be translated into orders, revenue and stronger cash flow," said Daniel Vallin, CEO of Cell Impact.

Financial summary:

  • Net sales totaled SEK 0.9 million (0.4).
  • The operating loss (EBIT) amounted to SEK -14.7 million (-21.7).
  • The Group's loss after financial items was SEK -10.6 million (-22.8).
  • Earnings per share attributable to the Parent Company's shareholders before and after dilution totaled SEK -0.01 (-0.14).
  • Debt/equity ratio was 86 percent (87) on the balance sheet date.
  • Cash flows from operating activities amounted to SEK -15.8 million (-19.6).
  • On the balance sheet date, the Group's cash and cash equivalents totaled SEK 11.2 million (6.7). As of November 5, 2026, the cash balance amounted to SEK 4.4 million.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.